Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-510791-20-00

Acronym

N-DAPMET-24-284

Enrollment

Registered

2025-08-06

Start date

2025-08-29

Completion date

2025-10-03

Last updated

2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026